Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
New research from the University of Michigan has explored the use of brain imaging in order to track the clinical action of a drug used to treat chronic pain. This is according to a study published in the journal Anesthesiology.
Using three different brain imaging procedures, the investigators were able to track the actions of pregabalin - a drug commonly used to treat patients suffering from fibromyalgia and neuropathic pain.
The researchers say their findings suggest that brain imaging techniques could be used to create targeted treatment approaches for patients who suffer chronic pain.
To reach their findings, the investigators analyzed the actions of pregabalin in 17 patients who were suffering from fibromyalgia - a chronic pain disorder that is thought to be caused by an impairment in the way pain is processed in the central nervous system.
According to the researchers, fibromyalgia affects approximately 10 million people in the US and 3-6% of the population worldwide.
The investigators note that previous research has shown that patients with fibromyalgia can have increased neural activity in the insula of the brain - a region associated with processing pain and emotion.
Research has also shown that heightened activity in the insula could be linked to increased levels of glutamate - a stimulative neurotransmitter in the brain.
Using proton magnetic resonance spectroscopy, functional magnetic resonance imaging (fMRI) and functional connectivity magnetic resonance imaging, the researchers found that pregabalin, commercially known as Lyrica, partly works by reducing glutamate concentration in the insula - which the researchers say is consistent with animal studies.
Furthermore, it was found that alongside decreased glutamate concentration, there were reductions in insula connectivity and patients' rating of clinical pain.
"These results corroborate our previous findings in both baseline fibromyalgia patients and in patients successfully treated by non-pharmacological therapy," the researchers say.
"Accumulating evidence suggests that insula-DMN (default mode network) connectivity may be useful as an objective biomarker for clinical pain in chronic pain patients."
Richard Harris, assistant professor of anesthesiology at the University of Michigan, says their findings are significant because it demonstrates that pharmacologic therapies for chronic pain can be studied with brain imaging.
"The results could point to a future in which more targeted brain imaging approaches can be used during pharmacological treatment of chronic widespread pain, rather than the current trial-and-error approach."
The investigators note that further work is needed to determine whether their findings can be applied to other pain syndromes and disorders associated with increased brain glutamate, such as neuropathic pain.
Medical News Today recently reported on a study revealing that researchers have identified hundreds of 'pain genes' through DNA sequencing.
Written by Honor Whiteman
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
Pregabalin Rectifies Aberrant Brain Chemistry, Connectivity, and Functional Response in Chronic Pain Patients, Harris, doi: 10.1097/ALN.0000000000000017, Richard E. PhD; Napadow, Vitaly PhD; Huggins, John P. PhD; Pauer, Lynne MS; Kim, Jieun PhD; Hampson, Johnson M.S; Sundgren, Pia C. MD; Foerster, Bradley MD; Petrou, Myria MD; Schmidt-Wilcke, Tobias MD; Clauw, Daniel J. MD, published in Anesthesiology, 19 November 2013. Open access
Brain imaging reveals dynamic changes caused by pain medicines, news release from the University of Michigan, accessed 21 November 2013.
Visit our Pain / Anesthetics category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Whiteman, Honor. "Brain imaging reveals how chronic pain drug works." Medical News Today. MediLexicon, Intl., 22 Nov. 2013. Web.
9 Mar. 2014. <http://www.medicalnewstoday.com/articles/269195>
Whiteman, H. (2013, November 22). "Brain imaging reveals how chronic pain drug works." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/269195.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.